Financials in USD. Standardized financial statements.
A compact view of how Abeona Therapeutics Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $5.82M | $0 | $3.50M | $1.41M | $3.00M | $10.00M | $0 | $3.00M | $837,000 | $889,000 |
| Revenue Growth? | 0.0% | -100.0% | +147.5% | -52.9% | -70.0% | 0.0% | -100.0% | +258.2% | -5.8% | 0.0% |
| Cost of Revenue? | $1.53M | $2.91M | $1.60M | $450,000 | $0 | $0 | $48.57M | $38.70M | $16.99M | $10.65M |
| Gross Profit? | $4.29M | -$2.91M | $1.90M | $964,000 | $3.00M | $10.00M | -$48.57M | -$35.70M | -$16.15M | -$9.77M |
| Gross Margin? | +73.7% | 0.0% | +54.1% | +68.2% | +100.0% | +100.0% | 0.0% | -1190.8% | -1929.7% | -1098.5% |
| Operating Expenses? | $93.74M | $61.30M | $49.03M | $51.88M | $92.84M | $91.42M | $28.52M | $61.16M | $28.67M | $24.77M |
| Operating Income? | -$89.45M | -$64.21M | -$47.13M | -$50.91M | -$89.84M | -$81.42M | -$77.09M | -$58.17M | -$27.84M | -$23.88M |
| EBITDA? | -$85.89M | -$56.62M | -$50.57M | -$34.38M | -$76.82M | -$74.52M | -$69.27M | -$54.31M | -$26.58M | -$21.05M |
| Income Before Tax | $71.28M | -$63.73M | -$54.19M | -$39.70M | -$84.94M | -$84.23M | -$76.28M | -$56.67M | -$27.32M | -$21.87M |
| Income Tax Expense | $100,000 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | $71.18M | -$63.73M | -$54.19M | -$39.70M | -$84.94M | -$84.23M | -$76.28M | -$56.67M | -$27.32M | -$21.87M |
| EPS? | $1.34 | $-1.55 | $-2.53 | $-5.53 | $-21.50 | $-22.75 | $-38.07 | $-29.81 | $-16.40 | $-16.00 |
| Diluted EPS? | $1.01 | $-1.55 | $-2.53 | $-5.53 | $-21.50 | $-22.75 | $-38.07 | $-29.81 | $-16.40 | $-16.00 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality